Figure 3From: Burden of illness and quality of life in patients being treated for seasonal allergic rhinitis: a cohort surveySymptom free days in patients with both nasal and ocular symptoms. Number of symptom free days in the past 4 weeks, in patients with a history of both ocular and nasal symptoms on each INS therapy. FF: Fluticasone furoate; FP: Fluticasone propionate; MF: Mometasone furoate; INS: intranasal corticosteroids.Back to article page